Hansoh Pharmaceutical Group CoHNSPF 90 Days Inventory is 136.25 as of Dec. 2025, which is 31% below its 10-year median of 196.92. GuruFocus rates HNSPF with a GF Score™ of 90/100 and a GF Value™ of $3.00 (Fairly Valued). Among 916 Drug Manufacturers companies, Hansoh Pharmaceutical Group Co ranks better than 54.8% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Hansoh Pharmaceutical Group Co's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.34.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Hansoh Pharmaceutical Group Co's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.08.
Hansoh Pharmaceutical Group Co (OTCPK:HNSPF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Hansoh Pharmaceutical Group Co's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Hansoh Pharmaceutical Group Co's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Hansoh Pharmaceutical Group Co Days Inventory Related Terms
Hansoh Pharmaceutical Group Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hansoh Pharmaceutical Group Co Days Inventory Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Hansoh Pharmaceutical Group Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hansoh Pharmaceutical Group Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hansoh Pharmaceutical Group Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Hansoh Pharmaceutical Group Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hansoh Pharmaceutical Group Co (HNSPF) has a Days Inventory of 136.25 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Hansoh Pharmaceutical Group Co and its competitors. This is 31% below median its historical median of 196.92. Over the past decade, Hansoh Pharmaceutical Group Co's Days Inventory has ranged from 146.69 to 324.37. According to the industry distribution chart, Hansoh Pharmaceutical Group Co ranks #414 out of 916 companies in the Drug Manufacturers industry, placing it in the top 45.2%.
Is Hansoh Pharmaceutical Group Co's Days Inventory too high?
Hansoh Pharmaceutical Group Co's current Days Inventory of 136.25 is 31% below median its 10-year median of 196.92. Over the past 10 years, this metric has ranged from a low of 146.69 to a high of 324.37. The Drug Manufacturers industry median Days Inventory is 164.43. Hansoh Pharmaceutical Group Co's value of 136.25 is 17.1% below this industry median. Based on the distribution chart, Hansoh Pharmaceutical Group Co ranks #414 out of 916 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Hansoh Pharmaceutical Group Co has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hansoh Pharmaceutical Group Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hansoh Pharmaceutical Group Co ranks #414 out of 916 companies for Days Inventory. This puts Hansoh Pharmaceutical Group Co in the upper half of its industry. The industry median Days Inventory is 164.43. Hansoh Pharmaceutical Group Co's value of 136.25 is 17.1% below this benchmark. Historically, Hansoh Pharmaceutical Group Co's own Days Inventory has ranged from 146.69 to 324.37 over the past decade. While the company's 10-year median is 196.92 vs. the industry median of 164.43, Hansoh Pharmaceutical Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hansoh Pharmaceutical Group Co's current Days Inventory of 136.25 is 17.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Hansoh Pharmaceutical Group Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hansoh Pharmaceutical Group Co's current Days Inventory is 136.25, which is 31% below median its own 10-year median of 196.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hansoh Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Hansoh Pharmaceutical Group Co (HNSPF) is currently considered Fairly Valued. The stock's GF Value™ is $3.00, compared to a current price of $3.83 — trading 27.5% above its estimated fair value. The current Days Inventory is 136.25, which is 31% below median its 10-year median of 196.92 and 17.1% below the Drug Manufacturers industry median of 164.43. Hansoh Pharmaceutical Group Co's overall GF Score™ is 90/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Hansoh Pharmaceutical Group Co (HNSPF), the current Days Inventory is 136.25 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hansoh Pharmaceutical Group Co (HNSPF) Overvalued in 2026?
Based on GuruFocus' analysis, Hansoh Pharmaceutical Group Co stock appears to be overvalued.
The current stock price of $3.83 is trading 27.5% above its estimated GF Value™ of $3.00.
GuruFocus considers Hansoh Pharmaceutical Group Co to be Fairly Valued.
Key valuation signals for HNSPF:
Days Inventory: 136.25 (31% below median its 10-year median of 196.92)
GF Value™: $3.00 vs. price of $3.83 (27.5% above fair value)
Industry Position: 17.1% below the Drug Manufacturers median (#414 of 916)
No single metric tells the full story. See the HNSPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hansoh Pharmaceutical Group Co Business Description
Hansoh Pharmaceutical Group Co Ltd is an investment holding company. The company were principally engaged in the research and development, production and sale of a series of pharmaceutical products in the People's Republic of China. It focuses on disease therapeutic areas such as oncology, anti-infectives, CNS, metabolism and immunology. The majority of Group's revenue was generated from the sale of pharmaceutical products in Chinese mainland.
90GF Score
Get the complete analysis for HNSPF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HNSPF has been successfully added to your 
